➀
16-1540_PPD-25-245 Extraneal PL-path.indd 1 25/7/16 16:46
Clinical Trial Adverse Reactions †
System Organ Class (SOC)
Preferred MedDRA Term Frequency*
Frequency Percentage
or Ratio N=493
➁
16-1540_PPD-25-245 Extraneal PL-path.indd 2 25/7/16 16:46
Clinical Trial Adverse Reactions †
System Organ Class (SOC)
Preferred MedDRA Term Frequency*
Frequency Percentage
or Ratio N=493
➂
16-1540_PPD-25-245 Extraneal PL-path.indd 3 25/7/16 16:46